SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-003205
Filing Date
2024-02-09
Accepted
2024-02-09 17:38:14
Documents
1
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 form4-02092024_100205.html 4  
1 form4-02092024_100205.xml 4 7084
  Complete submission text file 0001415889-24-003205.txt   8654
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address
Guerin Mark Patrick (Reporting) CIK: 0001607714 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 24616382